Vaishalee P Kenkre

Trials

Studies that name Vaishalee P Kenkre as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:50 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT07572123 · Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma

  National Cancer Institute (NCI) · not yet recruiting · Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma · principal investigator
• Ph3
  NCT05711628 · A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma

  National Cancer Institute (NCI) · withdrawn · Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma · principal investigator
• N/A
  NCT02652468 · TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma

  University of Wisconsin, Madison · completed · Lymphoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• ECOG-ACRIN Network Group Operations Center
  U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026
  Named on NCT07572123, NCT05711628